Early Diagnosis and Treatment of Discoid Lupus Erythematosus

References

1. ↵
   Fitzpatrick TB, Johnson RA, Klaus W, Suurmond D. In colour atlas and synopsis of clinical dermatology, 4th ed. New York (NY): McGraw-Hill Companies; 2001: 368–9.
2. ↵
   Lahita RG. In systemic lupus erythematosus, 2nd ed. New York (NY): Churchill Livingstone; 1987: 620.
3. ↵
   Tebbe B, Orfanos CE. [Lupus erythematosus of the skin. An analysis of 97 patients.] Z Hautkr 1987; 62: 1563–72, 1577–8, 1583–4.

   OpenUrlPubMedWeb of Science
4. ↵
   Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6: 96–104.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285–95.

   OpenUrlPubMed
6. ↵
   Hymes SR, Jordon RE. Chronic cutaneous lupus erythematosus. Med Clin N Am 1989; 73: 1055–71.

   OpenUrlPubMed
7. ↵
   Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 1992; 128: 368–71.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Jessop S, Whitelaw D, Jordaan F. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev 2001; (1): CD002954.
9. ↵
   Donnelly AM, Halbert AR, Rohr JB. Discoid lupus erythematosus. Australas J Dermatol 1995; 36: 3–10; quiz 11–2.

   OpenUrlPubMed
10. ↵
    Ting WW, Sontheimer RD. Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations. Lupus 2001; 10: 171–84.

    OpenUrlAbstract/FREE Full Text
11. ↵
    Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 2003; 149: 131–7.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Lehmann P, Holzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990; 22: 181–7.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol 2006; 47: 13–27.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Callen JP. Treatment of cutaneous lesions in patients with lupus erythematosus. Dermatol Clin 1994; 12: 201–6.

    OpenUrlPubMed
15. ↵
    von Schmiedeberg S, Rönnau AC, Schuppe HC, Specker C, Ruzicka T, Lehmann P. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus.] Hautarzt 2000; 51: 82–5.

    OpenUrlCrossRefPubMed
16. ↵
    Cruz DD. Antimalarial therapy: a panacea for mild lupus. Lupus 2001; 10: 148–51.

    OpenUrlAbstract/FREE Full Text
17. ↵
    Mackenzie AH. Dose refinements in the long term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983; 75: 40–5.

    OpenUrlPubMedWeb of Science
18. ↵
    Lo JS, Berg RE, Tomecki K. Treatment of discoid lupus erythematosus. Int J Dermatol 1989; 28: 497–505.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Ward Q, Walter-Ryan WG, Shehi GM. Toxic psychosis: a complication of antimalarial therapy. J Am Acad Dermatol 1985; 12: 863–5.

    OpenUrlPubMed
20. ↵
    Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 2003; 4: 449–65.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Brocard A, Barbarot S, Milpied B, Stalder JF. Thalidomide in the treatment of chronic discoid lupus erythematosus. Ann Dermatol Venereol 2005; 132(11 Pt 1): 853–6.

    OpenUrlPubMed
22. ↵
    Bottomley WW, Goodfield MJ. Methotrexate for the treatment of discoid lupus erythematosus. Br J Dermatol 1995; 133: 655–6.

    OpenUrlCrossRefPubMed
23. ↵
    Yell JA, Burge SM. Cyclosporin and discoid lupus erythematosus. Br J Dermatol 1994; 131: 132–48.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Walker SL, Kirby B, Chalmers RJ. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002; 147: 405–6.

    OpenUrlCrossRefPubMed
25. ↵
    Tzung TY, Liu YS, Chang HW. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol 2007; 156: 191–2.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999; 40(2 Pt 1): 265–7.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of palms and soles with mycophenolate mofetil. J Am Acad Dermatol 2001; 45: 142–4.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    Abu Shakra M, Shoenfield Y. Azathioprine therapy for patients with systemic lupus erythematosus. Lupus 2001; 10: 152–3.

    OpenUrlAbstract/FREE Full Text
29. ↵
    Gül U, Gönül M, Cakmak SK, Kiliç A, Demiriz M. A case of generalized discoid lupus erythematosus: successful treatment with imiquimod cream 5%. Adv Ther 2006; 23: 787–92

    OpenUrlCrossRefPubMed
30. ↵
    Usmani N, Goodfield M. Efalizumab in the treatment of discoid lupus erythematosus. Arch Dermatol 2007; 143: 873–7.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Koch M, Horwath-Winter J, Aberer E, Salmhofer W, Klein A. [Cryotherapy in discoid lupus erythematosus (DLE).] Ophthalmologe 2008; 105: 381–3.

    OpenUrlPubMed
32. ↵
    Callen JP. Management of refractory skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 2005; 19: 767–84.

    OpenUrlCrossRefPubMed